findmyKOL
Clinical trialNCT00721045CompletedPhase 2Interventional

A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure

SponsorMesoblast, Ltd.Enrollment60Heart Failure
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mercy Gilbert Medical Center

    Gilbert, Arizona, United States

  • University of California, San Diego

    La Jolla, California, United States

  • Minneapolis Heart Institute 920 East 28th St, Suite 300

    Minneapolis, Minnesota, United States

  • Upmc

    Pittsburgh, Pennsylvania, United States

  • Texas Heart Institue

    Houston, Texas, United States

  • Swedish Heart and Vascular Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2008
Primary completion
30 Jun 2011
Completion
31 Jul 2013
Last update posted
11 Mar 2020
Registered enrollment
60
Registry id
NCT00721045

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.